Formulation Development and Evaluation of Hybrid Nanocarrier for Cancer Therapy: Taguchi Orthogonal Array Based Design
Figure 6
Figure showing (a) particle size, nm; (b) Zeta potential, mV; (c) entrapment % of developed nanocarriers. C-ANC-G and C-HNC-G represents gemcitabine loaded albumin nanocarrier and hybrid nanocarrier, respectively, formulated using conventional method; while M-ANC-G and M-HNC-G represent gemcitabine loaded albumin nanocarrier and Hybrid nanocarrier, respectively, formulated using method modified using Taguchi orthogonal array design method. Results are represented as mean SD ().